TXT
46
-3
MLM
47
2
SBUX
36
-3
EQIX
62
2
EIX
75
3
BEN
42
-4
TMO
44
8
LRCX
39
2
CINF
45
-5
AA
48
4
URI
55
-3
JPM
67
-2
CFG
62
-6
GS
66
-2
WFC
75
-2
GOOGL
56
3
COST
60
4
FCX
59
5
PNR
66
-3
A
34
-2
TXT
46
-3
MLM
47
2
SBUX
36
-3
EQIX
62
2
EIX
75
3
BEN
42
-4
TMO
44
8
LRCX
39
2
CINF
45
-5
AA
48
4
URI
55
-3
JPM
67
-2
CFG
62
-6
GS
66
-2
WFC
75
-2
GOOGL
56
3
COST
60
4
FCX
59
5
PNR
66
-3
A
34
-2
Financhill
Back

PetroChina 10K Form

Sell
46

PCCYF
PetroChina

Last Price:
0.70
Seasonality Move:
4.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PCCYF News And Ratings

See the #1 stock for the next 7 days that we like better than PCCYF

PCCYF Financial Statistics

Sales & Book Value

Annual Sales: $425.67B
Cash Flow: $-40.03B
Price / Cash Flow: 0
Annual Sales: $1.16
Price / Book: 0.62

Profitability

EPS (TTM): 0.12280
Net Income (TTM): $22.58B
Gross Margin: $100.18B
Return on Equity: 9.77%
Return on Assets: 5.84%

PetroChina Earnings Forecast

Key PetroChina Financial Ratios

  • The Gross Profit Margin over the past 25 years for PCCYF is 23.53%.
  • The Selling, General & Administrative Expenses for PCCYF have been equal to 1.10% of Gross Profit Margin.
  • The Research & Development expenses have been 0.73% of Revenue.
  • The Interest Expense is 14.93% of Operating Income.
  • The Net Earning history of PCCYF is 5.35% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 13 years.

PetroChina Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Oil, Gas & Consumable Fuels
Sector: Energy
Current Symbol: PCCYF
Website: petrochina.com.cn

Debt

Debt-to-Equity Ratio: 0.15
Current Ratio: 0.95
Quick Ratio: 0.57

Price-to-Earnings

Trailing P/E Ratio: 5.77
Forward P/E Ratio: 0

PCCYF Technical Analysis vs Fundamental Analysis

Sell
46
PetroChina (PCCYF) is a Sell

Is PetroChina a Buy or a Sell?

  • PetroChina stock is rated a Sell
    The current PetroChina [PCCYF] share price is $0.71. The Score for PCCYF is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.